{
  "docId": "019de074-ead2-732b-8415-93449fe93e32",
  "docSlug": "9cc66a7a8f583a45c6978147aa12db97",
  "documentTitle": "Freeman Capital Management | Activist Presentation Deck | 95 slides",
  "authorId": "freeman-capital-management",
  "authorName": "Freeman Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 73,
  "pageCount": 95,
  "prevPage": 72,
  "nextPage": 74,
  "slideType": "other",
  "function": "plan_implementation",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The chart uses dashed lines to indicate reporting relationships.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-ead2-732b-8415-93449fe93e32/73",
  "deckHref": "/decks/019de074-ead2-732b-8415-93449fe93e32",
  "deckJsonHref": "/decks/019de074-ead2-732b-8415-93449fe93e32.json",
  "deckAnchorHref": "/decks/019de074-ead2-732b-8415-93449fe93e32#slide-73",
  "components": [
    {
      "bbox": {
        "h": 0.488,
        "w": 0.842,
        "x": 0.109,
        "y": 0.253
      },
      "kind": "diagram",
      "text": "CMO, Director of Toxicology, Clinical Scientist, Senior Director of Global Regulator Strategy, Senior Director of Clinical Operations, VP of Support Operations, Project Manager, CMC, QA, Director of Digital Medicine, Pharmaceutical Development, Patent Lawyer, Clinical Operation Personnel x 3, CRA",
      "attrs": null,
      "subkind": "org-chart",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "862784cd-1640-4188-94b4-6eb86c5a9b8f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.078,
        "w": 0.435,
        "x": 0.047,
        "y": 0.056
      },
      "kind": "title",
      "text": "Proposed Organization Chart",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1234be7e-401c-4793-aa38-d5ba758fa186",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "org-chart",
      "slug": null,
      "matchId": "c80ddb57-e893-4ef6-b02b-6f6912c64c6a",
      "evidence": "Visual hierarchy of roles and reporting lines",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 95,
      "from": 61,
      "beatId": "383f2f65-7b68-449f-b311-9bc0591c8aab",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The document presents Freeman Capital Management's plan to restore value in Mind Medicine, including bringing MM-120 to market quickly and safely, and aligning G&A and headcount.",
      "position": 2,
      "confidence": 0.9,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}